ATE300947T1 - Behandlung von erkrankungen mit zystenbildung - Google Patents
Behandlung von erkrankungen mit zystenbildungInfo
- Publication number
- ATE300947T1 ATE300947T1 AT99966268T AT99966268T ATE300947T1 AT E300947 T1 ATE300947 T1 AT E300947T1 AT 99966268 T AT99966268 T AT 99966268T AT 99966268 T AT99966268 T AT 99966268T AT E300947 T1 ATE300947 T1 AT E300947T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- diseases involving
- cyst formation
- diagnosis
- involving cyst
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11300898P | 1998-12-18 | 1998-12-18 | |
US13620899P | 1999-05-26 | 1999-05-26 | |
PCT/US1999/029763 WO2000037085A1 (en) | 1998-12-18 | 1999-12-15 | Treatment of diseases involving cyst formation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE300947T1 true ATE300947T1 (de) | 2005-08-15 |
Family
ID=26810615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99966268T ATE300947T1 (de) | 1998-12-18 | 1999-12-15 | Behandlung von erkrankungen mit zystenbildung |
Country Status (7)
Country | Link |
---|---|
US (2) | US6380183B1 (de) |
EP (1) | EP1140106B1 (de) |
AT (1) | ATE300947T1 (de) |
AU (1) | AU2185000A (de) |
DE (1) | DE69926535T2 (de) |
ES (1) | ES2246588T3 (de) |
WO (1) | WO2000037085A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2035038A4 (de) * | 2006-04-03 | 2011-04-06 | Stowers Inst For Medical Res | Zusammensetzungen und verfahren zur behandlung von polyzystischer nierenerkrankung |
US8429516B1 (en) * | 2007-08-20 | 2013-04-23 | Adobe Systems Incorporated | Media player feedback |
RU2505315C2 (ru) * | 2008-07-30 | 2014-01-27 | Нитто Денко Корпорейшн | Носители лекарственных средств |
CA2779161A1 (en) * | 2009-10-28 | 2011-05-05 | University Of Manitoba | Yellow pea seed protein-derived peptides |
EP3037518B1 (de) | 2014-12-28 | 2020-05-06 | Femtobiomed Inc. | Vorrichtung zum einbringen von material in eine zelle |
WO2019222559A1 (en) * | 2018-05-16 | 2019-11-21 | University Of Washington | High-throughput automation of organoids for identifying therapeutic strategies |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2525595A1 (fr) * | 1982-04-27 | 1983-10-28 | Pharmuka Lab | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
FR2599740B1 (fr) | 1986-06-05 | 1988-08-12 | Rhone Poulenc Sante | Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant |
US4898861A (en) * | 1987-03-26 | 1990-02-06 | Hoffmann-La Roche Inc. | Method for inhibiting the proliferation of tumor cells |
DK273689A (da) | 1988-06-06 | 1989-12-07 | Sanofi Sa | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler |
FR2659329B1 (fr) * | 1990-03-09 | 1994-06-03 | Adir | Nouveaux derives d'imidazo [1,2-c] quinazoline, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
US5091381A (en) * | 1991-04-12 | 1992-02-25 | Biomeasure, Inc. | 2H-1,3,4-benzotriazepin-2-ones |
US5550124A (en) * | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
US5789189A (en) | 1993-09-24 | 1998-08-04 | The Regents Of The University Of California | Inhibition of cyst formation by cytoskeletal specific drugs |
EP0663958A4 (de) | 1992-09-25 | 1999-10-20 | Woo David D L The Regents Of T | Hemmung der bildung von zysten mittels zytosklettspezifischer arzneimittel. |
IL117659A (en) | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
US5776946A (en) | 1995-08-28 | 1998-07-07 | Mcgeer; Patrick L. | Peripheral benzodiazepine receptor ligands as antiinflammatory agents |
US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
FR2779963A1 (fr) * | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer |
US6277844B1 (en) * | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
FR2785803B1 (fr) * | 1998-11-17 | 2005-03-25 | Sanofi Sa | Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes |
WO2001051922A2 (en) * | 2000-01-14 | 2001-07-19 | Mitokor | Identification of peripheral benzodiazepine receptor binding agents |
-
1999
- 1999-12-15 AU AU21850/00A patent/AU2185000A/en not_active Abandoned
- 1999-12-15 US US09/461,910 patent/US6380183B1/en not_active Expired - Lifetime
- 1999-12-15 WO PCT/US1999/029763 patent/WO2000037085A1/en active IP Right Grant
- 1999-12-15 DE DE69926535T patent/DE69926535T2/de not_active Expired - Fee Related
- 1999-12-15 AT AT99966268T patent/ATE300947T1/de not_active IP Right Cessation
- 1999-12-15 ES ES99966268T patent/ES2246588T3/es not_active Expired - Lifetime
- 1999-12-15 EP EP99966268A patent/EP1140106B1/de not_active Expired - Lifetime
-
2002
- 2002-04-30 US US10/136,807 patent/US20030008864A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69926535D1 (de) | 2005-09-08 |
US20030008864A1 (en) | 2003-01-09 |
AU2185000A (en) | 2000-07-12 |
WO2000037085A1 (en) | 2000-06-29 |
ES2246588T3 (es) | 2006-02-16 |
DE69926535T2 (de) | 2006-03-30 |
US6380183B1 (en) | 2002-04-30 |
EP1140106B1 (de) | 2005-08-03 |
EP1140106A1 (de) | 2001-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109650A (pt) | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca | |
ATE218854T1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
CY1108274T1 (el) | Μακροβιο ομοιαζον με γλυκογονο πεπτιδιο 2 (glp-2) για την θεραπεια γαστρεντερικων ασθενειων και διαταραχων | |
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
DE69925024D1 (de) | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
BR9912053A (pt) | Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
DK0841949T3 (da) | Anvendelse af saccharid-konjugater | |
ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
PT815087E (pt) | Derivados de fenilo trissubstituidos | |
DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
DE69935853D1 (de) | Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten | |
ATE300947T1 (de) | Behandlung von erkrankungen mit zystenbildung | |
DE69841322D1 (de) | Hepatitis c rezeptorprotein cd81 | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
HUP0002836A2 (hu) | Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
EA200000909A1 (ru) | ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА | |
ATE302008T1 (de) | Behandlung von entzündlichen erkrankungen | |
NO20005548D0 (no) | Mykobakterieinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |